Skip to main content
. 2016 Sep 23;33(11):1947–1963. doi: 10.1007/s12325-016-0406-6

Fig. 1.

Fig. 1

Kaplan–Meier plot of time to switch or discontinuation by treatment group. ADA adalimumab, IFX infliximab